NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury
- PMID: 31734560
- PMCID: PMC6861628
- DOI: 10.1016/j.omtn.2019.08.028
NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury
Abstract
Acute lung injury (ALI) is a pulmonary disorder that causes acute respiratory failure, thus leading to relative high mortality worldwide. However, the molecular mechanisms of ALI remain largely unknown. MicroRNA (miRNA)-dependent control of gene expression at a post-transcriptional level has been recently reported. Herein, we identify a candidate miRNA, miR-495, that affects the progression of ALI. Alveolar macrophages (NR8383) were treated with 1 μg/mL lipopolysaccharide (LPS) to establish a cell-injury model. Combined with the data from western blot, methylation-specific PCR, methylated DNA immunoprecipitation, and chromatin immunoprecipitation assays, NLRP3 inflammasome activation and methylation-dependent repression of miR-495 were found in LPS-exposed NR8383 cells. Dual-luciferase reporter gene assay and miR-495 gain-of-function experiments confirmed that NLRP3 was a target of miR-495. Next, the expression of miR-495 and NLRP3 was overexpressed or silenced to assess their effects on NLRP3 inflammasome activation, alveolar macrophage inflammation, and pyroptosis in vitro. As demonstrated, overexpressed miR-495 alleviated alveolar macrophage inflammation and pyroptosis and inhibited NLRP3 inflammasome activation by negatively regulating the NLRP3 gene. Consistently, elevated miR-495 alleviated lung injury and reduced the neutrophil infiltration and inflammation in rat models of LPS-induced ALI. Taken together, the data in our study demonstrated that methylation of the miR-495 promoter could downregulate miR-495, whose elevation could attenuate the activation of the NLRP3 inflammasome to protect against ALI, which provides novel therapeutic targets for ALI treatment.
Keywords: NOD-like receptor family pyrin domain containing 3; acute lung injury; inflammasome; methylation; microRNA-495.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Lemos-Filho L.B., Mikkelsen M.E., Martin G.S., Dabbagh O., Adesanya A., Gentile N., Esper A., Gajic O., Gong M.N., US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS) Sex, race, and the development of acute lung injury. Chest. 2013;143:901–909. - PMC - PubMed
-
- Dushianthan A., Grocott M.P., Postle A.D., Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad. Med. J. 2011;87:612–622. - PubMed
-
- Czyzewski A.M., McCaig L.M., Dohm M.T., Broering L.A., Yao L.J., Brown N.J., Didwania M.K., Lin J.S., Lewis J.F., Veldhuizen R., Barron A.E. Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins. Sci. Rep. 2018;8:6795. - PMC - PubMed
-
- Butt Y., Kurdowska A., Allen T.C. Acute lung injury: a clinical and molecular review. Arch. Pathol. Lab. Med. 2016;140:345–350. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
